Cargando…
Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report
Amyloidosis is a systemic disease that results from the extracellular deposition of an abnormal protein called amyloid. The kidney and the heart are the most common organ affected by amyloidosis while in some cases liver involvement can be seen. Our patient is a 60-year-old African American male who...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403217/ https://www.ncbi.nlm.nih.gov/pubmed/36039232 http://dx.doi.org/10.7759/cureus.27274 |
_version_ | 1784773324025364480 |
---|---|
author | Ghazanfar, Haider Khaja, Misbahuddin Haider, Asim Yapor, Laura Kandhi, Sameer Sulh, Muhammad |
author_facet | Ghazanfar, Haider Khaja, Misbahuddin Haider, Asim Yapor, Laura Kandhi, Sameer Sulh, Muhammad |
author_sort | Ghazanfar, Haider |
collection | PubMed |
description | Amyloidosis is a systemic disease that results from the extracellular deposition of an abnormal protein called amyloid. The kidney and the heart are the most common organ affected by amyloidosis while in some cases liver involvement can be seen. Our patient is a 60-year-old African American male who presented to the emergency department because of multiple episodes of syncope over the past day. Chest x-ray and ultrasound chest were suggestive of pleural effusion for which thoracentesis was done. His hospital course was complicated with renal and liver failure. Computed tomography (CT) abdomen and pelvis was done which showed mild hepatomegaly. Liver biopsy was done which showed congo red stain positive for amyloid. The patient's clinical condition continued to worsen and he was started on hemodialysis. During hospital course, the patient developed liver failure. His family members opted for palliative care and the patient passed away during the same admission. Physicians need to be aware of the detrimental course and poor prognosis associated with hepatic and renal amyloidosis. High clinical suspicion is needed to make an early diagnosis and initiate prompt treatment. Although clinical, laboratory and radiological findings can help in suggesting amyloidosis, a tissue biopsy is needed to confirm the diagnosis of amyloidosis. |
format | Online Article Text |
id | pubmed-9403217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-94032172022-08-28 Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report Ghazanfar, Haider Khaja, Misbahuddin Haider, Asim Yapor, Laura Kandhi, Sameer Sulh, Muhammad Cureus Internal Medicine Amyloidosis is a systemic disease that results from the extracellular deposition of an abnormal protein called amyloid. The kidney and the heart are the most common organ affected by amyloidosis while in some cases liver involvement can be seen. Our patient is a 60-year-old African American male who presented to the emergency department because of multiple episodes of syncope over the past day. Chest x-ray and ultrasound chest were suggestive of pleural effusion for which thoracentesis was done. His hospital course was complicated with renal and liver failure. Computed tomography (CT) abdomen and pelvis was done which showed mild hepatomegaly. Liver biopsy was done which showed congo red stain positive for amyloid. The patient's clinical condition continued to worsen and he was started on hemodialysis. During hospital course, the patient developed liver failure. His family members opted for palliative care and the patient passed away during the same admission. Physicians need to be aware of the detrimental course and poor prognosis associated with hepatic and renal amyloidosis. High clinical suspicion is needed to make an early diagnosis and initiate prompt treatment. Although clinical, laboratory and radiological findings can help in suggesting amyloidosis, a tissue biopsy is needed to confirm the diagnosis of amyloidosis. Cureus 2022-07-26 /pmc/articles/PMC9403217/ /pubmed/36039232 http://dx.doi.org/10.7759/cureus.27274 Text en Copyright © 2022, Ghazanfar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Ghazanfar, Haider Khaja, Misbahuddin Haider, Asim Yapor, Laura Kandhi, Sameer Sulh, Muhammad Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title | Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title_full | Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title_fullStr | Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title_full_unstemmed | Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title_short | Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report |
title_sort | hepatic amyloidosis as a rare cause of liver failure: a case report |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403217/ https://www.ncbi.nlm.nih.gov/pubmed/36039232 http://dx.doi.org/10.7759/cureus.27274 |
work_keys_str_mv | AT ghazanfarhaider hepaticamyloidosisasararecauseofliverfailureacasereport AT khajamisbahuddin hepaticamyloidosisasararecauseofliverfailureacasereport AT haiderasim hepaticamyloidosisasararecauseofliverfailureacasereport AT yaporlaura hepaticamyloidosisasararecauseofliverfailureacasereport AT kandhisameer hepaticamyloidosisasararecauseofliverfailureacasereport AT sulhmuhammad hepaticamyloidosisasararecauseofliverfailureacasereport |